Literature DB >> 3881562

Adjuvant systemic therapy for resectable breast cancer.

G Bonadonna, P Valagussa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3881562     DOI： 10.1200/JCO.1985.3.2.259

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  13 in total

1.  Relationship of estrogen and progesterone receptors to prognosis in breast cancer.

Authors:  G A Gelbfish; A L Davidson; S Kopel; B Schreibman; J S Gelbfish; G A Degenshein; B L Herz; J N Cunningham
Journal:  Ann Surg       Date:  1988-01       Impact factor: 12.969

2.  Adjuvant chemotherapy in postmenopausal women: results of sequential noncross-resistant regimens.

Authors:  C Brambilla; A Rossi; P Valagussa; G Bonadonna
Journal:  World J Surg       Date:  1985-10       Impact factor: 3.352

3.  A randomized trial of CMF versus CMFVP as adjuvant chemotherapy in women with node-positive stage II breast cancer: a CALGB Study.

Authors:  W C Wood; R B Weiss; D C Tormey; J F Holland; P H Henry; L A Leone; S Rafla; R T Silver; R W Carey; G J Lesnick
Journal:  World J Surg       Date:  1985-10       Impact factor: 3.352

4.  Adjuvant CMF chemotherapy in operable breast cancer: ten years later.

Authors:  G Bonadonna; A Rossi; P Valagussa
Journal:  World J Surg       Date:  1985-10       Impact factor: 3.352

5.  Effect on Antioxidant Levels in Patients of Breast Carcinoma during Neoadjuvant Chemotherapy and Mastectomy.

Authors:  Gurpreet Singh; Sk Maulik; Amardeep Jaiswal; Pratik Kumar; Rajinder Parshad
Journal:  Malays J Med Sci       Date:  2010-04

6.  Therapeutic strategies in inflammatory breast carcinoma based on prognostic factors.

Authors:  J Rouëssé; S Friedman; H Mouriesse; D Sarrazin; M Spielmann
Journal:  Breast Cancer Res Treat       Date:  1990-07       Impact factor: 4.872

7.  Possible adverse effect of failed adjuvant chemotherapy on the prognosis of women receiving consecutive chemotherapy for recurrent breast cancer.

Authors:  C Dittrich; R Jakesz; K Pirich; L Havelec; G Steger; O Schlappack; R Kolb; K Moser
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

Review 8.  Antibody-mediated targeting in the treatment and diagnosis of cancer: an overview.

Authors:  C H Ford; A G Casson
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

Review 9.  Ovarian preservation by GnRH agonists during chemotherapy: a meta-analysis.

Authors:  Megan E B Clowse; Millie A Behera; Carey K Anders; Susannah Copland; Cynthia J Coffman; Phyllis C Leppert; Lori A Bastian
Journal:  J Womens Health (Larchmt)       Date:  2009-03       Impact factor: 2.681

10.  Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancer.

Authors:  G Bonadonna; P Valagussa; A Rossi; G Tancini; C Brambilla; M Zambetti; U Veronesi
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.